Chemistry:Ingavirin

From HandWiki

Ingavirin (Ingamine, Vitavirin) is an antiviral drug developed in Russia, with activity against respiratory viruses such as influenza, COVID-19 and human metapneumovirus.[1][2][3][4][5]

References

  1. ↑ "[Efficacy of ingavirin in adults with influenza]". Terapevticheskii Arkhiv 81 (3): 51–54. 2009. PMID 19459424. 
  2. ↑ "[In vitro investigation of the antiviral activity of Ingavirin against human metapneumovirus]". Voprosy Virusologii 57 (1): 34–38. 2012. PMID 22624471. 
  3. ↑ "[Current principles in the chemoprophylaxis of acute respiratory viral infections]". Terapevticheskii Arkhiv 85 (11): 27–33. 2013. PMID 24432596. 
  4. ↑ "Ingavirin might be a promising agent to combat Severe Acute Respiratory Coronavirus 2 (SARS-CoV-2)". Ceska a Slovenska Farmacie 69 (3): 107–111. 2020. doi:10.36290/csf.2020.017. PMID 32972153. 
  5. ↑ "[Pharmacotherapy for acute respiratory infections caused by influenza viruses: current possibilities]". Terapevticheskii Arkhiv 93 (1): 114–124. January 2021. doi:10.26442/00403660.2021.01.200551. PMID 33720636. 



Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:Ingavirin&oldid=4035760"